Landos Biopharma, Inc. Profile Avatar - Palmy Investing

Landos Biopharma, Inc.

Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic c…

Biotechnology
US, Blacksburg [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of LABP's Analysis
CIK: 1785345 CUSIP: 515069102 ISIN: US5150692011 LEI: - UEI: -
Secondary Listings
LABP has no secondary listings inside our databases.